UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Papillomavirus | 5-Aza-2'-Deoxycytidine | Epigénétique | 616.9 | Epigenetics | Cancer | TBX2 | MiR-375
Dissertation
5-aza-2’-deoxycytidine | Inhibiteurs des ADN méthyltransférases | 5-aza-2’-désoxycytidine | DNA methyltransferases inhibitors | Épigénétique | Hdac2 | Medial prefrontal cortex | 616.8 | Méthylation de l’ADN | Cortex préfrontal médian | Cocaine self-administration | Epigenetics | DNA methylation | Auto-administration de cocaïne | 572.8
Dissertation
Molecular oncology, ISSN 1574-7891, 01/2017, Volume 11, Issue 8, pp. 1007 - 1022
NGFR | Neurotrophin pathway | Everolimus | Medullary thyroid cancer | MTOR | 5-aza-2'-deoxycytidine | medullary thyroid cancer | mTOR | neurotrophin pathway | everolimus | 5‐aza‐2′‐deoxycytidine | 5-aza-2′-deoxycytidine | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Neuroendocrine - metabolism | Genome-Wide Association Study | Everolimus - pharmacology | Neoplasm Proteins - biosynthesis | Carcinoma, Neuroendocrine - drug therapy | Humans | Azacitidine - analogs & derivatives | Azacitidine - agonists | Drug Synergism | Azacitidine - pharmacology | Thyroid Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Gene Expression Regulation, Neoplastic - drug effects | Everolimus - agonists | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | TOR protein | Bax protein | p53 Protein | Cytotoxicity | AKT protein | Genomes | Radiation therapy | Tumor cell lines | Drug resistance | Western blotting | 1-Phosphatidylinositol 3-kinase | Thyroid carcinoma | Signal transduction | Cell growth | Thyroid cancer | Nerve growth factor receptors | DNA methylation | Extracellular matrix | Mutation | Neuroendocrine tumors | Thyroid | Apoptosis | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 01/2021, Volume 142, pp. 150 - 151
Journal Article
The lancet oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 216 - 228
Journal Article
Cell cycle (Georgetown, Tex.), ISSN 1538-4101, 12/2019, Volume 18, Issue 23, pp. 3251 - 3262
Journal Article
Cell cycle (Georgetown, Tex.), ISSN 1538-4101, 12/2014, Volume 13, Issue 24, pp. 3927 - 3937
Senescence | RNA-seq | adriamycin | hydrogen peroxide | Li Fraumeni Syndrome | aging | 5-aza-2'-deoxycytidine | Hydrogen peroxide | Adriamycin | Aging | Li fraumeni syndrome | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Hydrogen Peroxide - toxicity | Interleukin-1 - genetics | Interleukin-1 - metabolism | Gene Expression - drug effects | Humans | Cellular Senescence - drug effects | Azacitidine - analogs & derivatives | Gene Expression Profiling | Azacitidine - toxicity | Doxorubicin - toxicity | Cyclin A2 - metabolism | Sequence Analysis, RNA | Cell Line, Tumor | Cyclin A2 - genetics | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 4, pp. 6955 - 6969
Molecular targets | Epigenetics | HCC | 5-Aza-2'-deoxycytidine | MicroRNAs | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Liver Neoplasms - genetics | Down-Regulation | Humans | Gene Expression Regulation, Neoplastic | Azacitidine - analogs & derivatives | Decitabine | Male | Hep G2 Cells | Azacitidine - pharmacology | Cell Movement - drug effects | Disease-Free Survival | Carcinoma, Hepatocellular - genetics | Cell Line, Tumor | Female | Cell Proliferation - drug effects | Epigenesis, Genetic - drug effects | MicroRNAs - genetics | DNA Methylation - drug effects | Index Medicus
Journal Article
Cancer management and research, ISSN 1179-1322, 01/2020, Volume 12, pp. 6969 - 6976
Journal Article
International journal of preventive medicine, ISSN 2008-7802, 01/2020, Volume 11, Issue 1, pp. 147 - 147
Journal Article
BMC genomics, ISSN 1471-2164, 02/2015, Volume 16, Issue 1, pp. 56 - 56
Gene ontology | Ionizing radiation | Colon cancer | DNA hypomethylation | 5-aza-2'-deoxycytidine | Methylation profiling | Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Promoter Regions, Genetic | Colonic Neoplasms - genetics | Genome, Human - radiation effects | Epigenesis, Genetic | HCT116 Cells | Humans | DNA Methylation - genetics | DNA (Cytosine-5-)-Methyltransferases - genetics | Neoplasms, Radiation-Induced - genetics | DNA Methylation - radiation effects | Colonic Neoplasms - pathology | CpG Islands | Gene Expression Regulation, Neoplastic - radiation effects | Neoplasms, Radiation-Induced - pathology | Gene Expression Regulation, Neoplastic - genetics | Radiation, Ionizing | Chromatin | Methyltransferases | Genes | Index Medicus
Journal Article
Biomedicine & pharmacotherapy, ISSN 0753-3322, 2012, Volume 67, Issue 1, pp. 78 - 87
Journal Article
The lancet oncology, ISSN 1470-2045, 12/2018, Volume 19, Issue 12, pp. e672 - e672
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 38, pp. 64114 - 64128
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2023 - 2036
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Azacitidine - adverse effects | Prospective Studies | Humans | Middle Aged | Decitabine | Male | Tumor Suppressor Protein p53 - genetics | Antimetabolites, Antineoplastic - administration & dosage | Exome | Bone Marrow - chemistry | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | 5-Methylcytosine - analysis | Biomarkers, Tumor - analysis | Risk Factors | Azacitidine - analogs & derivatives | Survival Rate | Leukemia, Myeloid, Acute - mortality | Bone Marrow - pathology | Antimetabolites, Antineoplastic - adverse effects | Myelodysplastic Syndromes - mortality | Aged | Myelodysplastic Syndromes - genetics | Mutation | Leukemia, Myeloid, Acute - genetics | Care and treatment | Research | Tumor proteins | Myelodysplastic syndromes | Myeloid leukemia | p53 Protein | Leukemia | Survival | Myelodysplastic syndrome | Risk factors | Clinical outcomes | Chemotherapy | Bone marrow | Biomarkers | Blood diseases | Acute myeloid leukemia | 5-aza-2'-deoxycytidine | Index Medicus | Abridged Index Medicus
Journal Article